Affiliation:
1. Division of Microbiology, Department of Pathology, Faculty of Medicine University of Porto Porto Portugal
2. Centre for Health Technology and Services Research/Health Research Network (CINTESIS@RISE) Faculty of Medicine of the University of Porto Porto Portugal
3. Department of Dermatology and Venereology University Hospital Center of São João Porto Portugal
Abstract
AbstractBackgroundThere is a recent growing global concern regarding the rise in antifungal resistance of dermatophytosis. The emergence of terbinafine‐resistant Trichophyton indotineae (T. indotineae), previously known as Trichophyton mentagrophytes genotype VIII, is particularly alarming given that terbinafine is considered the treatment of choice for dermatophyte infections and the limited number of available antimycotics. This strain surfaced in the Indian subcontinent in the mid‐2010s and more recently there have been reports of its arrival in Europe.ObjectiveThe objective of this review is to document the presence of terbinafine‐resistant T. indotineae in Europe with the aim to guide antifungal stewardship and ultimately prevent the spread of resistance.MethodsThis study was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) guidelines. A systematic literature search was performed using PubMed, Scopus and Web of Science databases.ResultsWe extracted information from 16 studies published between 2019 and 2023 that described a total of 63 cases of antifungal‐resistant dermatophytosis caused by T. indotineae in Europe. Antifungal susceptibility testing (AFST) revealed a wide range of terbinafine minimum inhibitory concentrations (MICs), varying from 0.014 to ≥16 μg/mL. However, these values are hard to interpret due to variations among used methodologies as well as the lack of clinical breakpoints. In all cases included in this study, elevated terbinafine MICs were associated with mutations in the squalene epoxidase (SQLE) gene. Itraconazole was the most frequently used alternative to terbinafine in this study and complete remission of tinea lesions after treatment switch was shown. Nevertheless, relapse rates are concerningly high.ConclusionWe propose the implementation of surveillance programmes for a fast identification through sequencing of T. indotineae (and SQLE mutations) and standardization of procedures for AFST to facilitate the establishment of clinical breakpoints and enable guidance on the appropriate use of antifungals.